📌 Key Takeaways
- Topic: 2500 Mesh Silica: Particle Size, Specifications and Common Applications
- Keywords: silica for coatings
- Published: 2026-11-20 03:00:28
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Magnetic particles were synthesized with an iron-containing coating. The model drugs were safranin O and hydrocortisone. The particles were functionalized with a bulky azo derivative to act as a gatekeeper and stop early leakage of the drug. In vitro release models have demonstrated that most of the drug is released only in the colon, as desired. This is owing to the reductive environment in the colon (the presence of the azoreductase enzyme), where the enzymatic degradation of the azo bond resulted in controlled release. In addition, in vivo pharmacokinetic studies were conducted in a rat model of induced colitis to test the effect of the magnetic field during therapy. The findings boosted when the rats wore a magnetic belt, which extended the retention time of the particles in the desired areas [ 75 ]. Zhang et al. presented a study in which magnetic silica nanoparticles (filled with sulforaphane) were developed for the treatment of myocardial infarction [ 38 ]. In mouse models, effective accumulation was observed in the infarcted zone after the application of an external magnetic field [ 33, 75 ]. These results show the potential of using magnetic particles with magnetic field guidance [ 33 ]. Radhakrishnan et al. developed a drug delivery system (DDS) loaded with carboplatin for targeted lung cancer therapy [ 63 ]. The DDS was core-shell mesoporous silica functionalized with folic acid. Initially, the drug loading capability of the functionalized carrier was more than twice as high per surface unit compared to the non-functionalized carrier due to the anchored -NH 2 groups. The drug release was sustained but limited (up to 36%) in the case of the functionalized particle, similarly to previous cases. This is most likely owing to the stronger interactions between the amine groups and the carboplatin. The amino-functionalized particles were further functionalized with folic acid to increase cellular uptake of the particles, demonstrating the potential of folic acid-targeted therapy [ 63, 65, 76 ]. Cancer cells typically overexpress folate receptors, resulting in folate-mediated internalization that preferentially targets these cells [ 63, 76 ]. This was demonstrated in a drug-mediated cytotoxicity analysis where amino- and folate-functionalized particles were evaluated and compared. Much greater cytotoxicity was observed in cells overexpressing folate receptors [ 63 ]. Similar research was carried out by Shirani et al., where folic acid functionalized MSNs were loaded with gemcitabine as a model drug, to investigate its potential in cancer treatment, while actively targeting cancer cells [ 70 ]. Outcomes have shown that higher cellular uptake (HeLa and K562 cells) was observed in the case of the functionalized particles, compared with the non-functionalized carriers [ 70 ]. Jafarpour et al. demonstrated the importance of functionalizing the carriers to accomplish targeted therapy utilizing methotrexate as a model drug [ 76 ]. The particles were grafted with a copolymer to act as a pH-responsive gatekeeper and folic acid to actively target cancer cells [ 76 ]. Ortiz et al. similarly designed a pH-responsive DDS, loaded with the anticancer drug doxorubicin [ 11 ]. The particles were functionalized with transferrin through a pH-sensitive linker as a gatekeeper, controlling the release kinetics and preventing early leakage of the drug [ 11 ]. An interesting breast cancer therapy was published by Mal et al. using doxorubicin as API and mesoporous silica as a carrier [ 65 ]. The amine-functionalized MSNs were PEGylated and then conjugated with folic acid or hyaluronic acid. It was also published that coating the nanoparticles with polydopamine (PDA) and polyethylene glycol (PEG) brings about prolonged doxorubicin release from MSNs [ 77 ]. These conjugates enabled ligand-mediated targeted drug delivery [ 65 ]. Researchers have developed a successful DDS that targets cancer cells, thus staying away from the side effects associated with doxorubicin in conventional cancer therapy. This is important because in vitro cytotoxicity studies have shown that the free drug has higher cytotoxicity than the nanocarriers [ 65 ]. Shahbaz et al. developed a redox-responsive silica nanocarrier loaded with paclitaxel to target breast cancer cells [ 67 ]. The amine-functionalized silica core was coated with disulfide-functionalized non-porous silica shell. Then the core-shell carriers were further coated with polyethylene glycol via disulfide linkages. In vitro drug release assay verified the correlation between the redox potential of the environment and the release kinetics. This is an important finding, as it has been revealed that cancer cells possess a higher redox ability than healthy cells. This provides controlled paclitaxel release for targeted therapy. According to cell uptake and cell viability assays, this DDS is noticeably more effective than free paclitaxel, making this nanocarrier an exciting prospect [ 67 ]. These illustrations highlight the importance of surface functionalization and employing stimuli-responsive gatekeepers to attain productive targeted therapy.
Silicone vs Silica: What Is the Difference and Where Is Each Used?
- Transparent Silica Filler: How to Keep Clarity in Coatings and Resins
- What Is the Molar Mass of Silicon Dioxide (SiO₂)? Calculation Explained
- Fumed Silica Alternatives: Cost-Effective Substitutes and How They Compare
- Mesoporous silica nanoparticles have poor powder rheology and poor flow properties, due to their low bulk density, small particle size, and high hygroscopicity, which make further processing and formulation, especially with direct compression, difficult [ 104 ]. This issue can be eliminated by granulating the carriers. Flowability and compactibility can also be boosted by granulation [ 86, 104 ]. During granulation, the desired degree of dispersity is attained by agglomeration of the particles, thereby creating a best possible flow characteristic. However, it is true that during granulation, the specific surface area and the pore volume of the carrier may decrease, also decreasing its adsorption capacity, which is a disadvantage from the facet of the API absorption [ 104, 105 ]. However, since this reduction is mostly negligible compared to the total specific surface area, a substantial improvement in its flow properties can considerably improve the overall performance [ 104, 105 ]. The critical parameters for the process are the following: the quantity of granulating liquid, the liquid addition rate, the mixing speed, the process time, and the temperature. Of course, the applied binder also plays an essential part in the process [ 105 ]. These parameters affect the granule size, specific surface area, bulk density, flow properties (Hausner-factor, Carr-index), crushing strength, compressibility, and compactibility [ 105 ].
- Wood Coating Matting Agent: How to Achieve a Low-Gloss, Clear Finish
- Oral route is one of the most trustworthy and well-liked ways of drug administration, as it is one of the simplest and most convenient ways for self-medication [ 25, 56 ]. The gastrointestinal system offers an outstanding absorption surface for the introduction of the API into the systemic circulation [ 25 ]. Nevertheless, in the case of molecules with poor water solubility and poor permeability, drug formulation involves many difficulties, which can be solved by using nanocarriers [ 42, 56 ]. Ndayishimiye et al. proved that vancomycin, a high molecular weight and hydrophilic antibiotic macromolecule with poor oral bioavailability, can be effectively encapsulated using silica nanocarriers, and therefore, the necessary oral bioavailability can be made sure to eliminate the injection-related side effects [ 14 ]. The in vitro study showed a prolonged drug release from the nanocarriers compared to the pure drug form, and the in vitro permeability through Caco-2 cells revealed a significant boost in the permeation for the encapsulated drug compared to the unencapsulated form [ 14 ]. These nanocarriers may also protect pH-sensitive molecules from the acidic environment of the stomach, thereby avoiding unwanted chemical changes, and moreover, they may also protect macromolecules from enzymatic degradation [ 25, 56 ]. Based on diverse experiments, several key elements greatly influence the effectiveness of the therapy. The optimal size range was established between 50 and 200 nm [ 13 ]. Particles smaller than this are trapped in the mucus layer, and larger ones cannot pass through the tight junctions [ 13 ]. Anionic surface boosts enteral permeability [ 13, 14 ]. Overall, enteral bioavailability can be improved at several points.
5N Quartz Sand: Purity Specifications, Key Impurities and High-Tech Applications
What is silica (SiO₂)?
silica for refractory
What is the difference between fumed silica and precipitated silica?
silica reinforcing agent
What drives silica raw material prices?
precipitated silica price
Cite this article: Silica Raw Materials News. "Silica for Optical Fiber: Purity Requirements and Manufacturing Role
." Published 2026-11-20 03:00:28.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.